M06.36 Rheumatoid nodule, knee

Name of the Condition

• Rheumatoid nodule, knee

Summary

Rheumatoid nodule, knee is a localized extra-articular manifestation of rheumatoid arthritis (RA) involving firm, subcutaneous nodules in the knee region. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. The exact pathogenesis involves dysregulated immune responses, including the activation of fibroblast-like synoviocytes and the production of pro-inflammatory cytokines. Genetic factors, such as HLA-DRB1 alleles, and environmental triggers (e.g., smoking) may contribute to their development in individuals with RA.

Risk Factors

• Severe, long-standing rheumatoid arthritis (especially seropositive disease).
• High rheumatoid factor or anti-CCP antibody titers.
• Presence of other extra-articular RA manifestations (e.g., vasculitis).
• Chronic inflammation and immune dysregulation.
• Trauma or pressure to affected areas.

Symptoms

• Firm, movable subcutaneous nodules in the knee area.
• Nodules may be painless or tender.
• May be associated with underlying joint inflammation or swelling.

Diagnosis

Diagnosis is typically clinical, based on the presence of firm subcutaneous nodules in the knee region and correlation with a history of rheumatoid arthritis. Imaging (e.g., ultrasound) may be used to confirm the presence of nodules and rule out other conditions. Laboratory tests for rheumatoid factor or anti-CCP antibodies may support the diagnosis but are not definitive for nodules alone.

Treatment Options

Treatment focuses on managing underlying rheumatoid arthritis, as nodules often improve with disease control. Options include disease-modifying antirheumatic drugs (DMARDs), biologic agents, or corticosteroids. Localized nodules may be monitored or surgically removed if symptomatic or cosmetically concerning.

Prognosis and Follow-Up

Prognosis depends on the severity of underlying RA. Nodules may persist or fluctuate with disease activity. Regular follow-up with a rheumatologist is recommended to monitor RA progression and adjust treatment as needed.

Complications

• Ulceration or infection of nodules, particularly if traumatized.
• Functional impairment if nodules affect joint mobility.
• Psychosocial impact due to visible nodules.

Lifestyle & Prevention

• Disease control: Adhere to RA treatment plans to reduce nodule formation.
• Avoid trauma: Protect knees from injury or pressure.
• Smoking cessation: Smoking may increase nodule risk and severity.

When to Seek Professional Help

Seek medical attention if nodules become painful, ulcerated, or increase in size, or if knee pain or swelling worsens.

Tips for Medical Coders

Code M06.36 is specific to rheumatoid nodules located in the knee. Documentation should specify the anatomical site and confirm association with rheumatoid arthritis. Ensure clinical correlation with RA diagnosis and exclude other causes of subcutaneous nodules.